Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

59.94 -4.02 (-6.29%)
Streaming Delayed Price Updated: 9:40 AM EDT, Jun 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 874,036
Open 64.07
Bid (Size) 59.78 (100)
Ask (Size) 60.09 (300)
Prev. Close 63.96
Today's Range 59.66 - 65.51
52wk Range 22.28 - 67.74
Shares Outstanding 394,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence
News headline image
Moderna Has Some Key Approvals Ahead. Is the Stock a Buy? ↗
The company's pending vaccine approvals could help the stock continue its rise. 
Via The Motley Fool

Performance

YTD
+94.2%
+94.2%
1 Month
+27.8%
+27.8%
3 Month
+16.9%
+16.9%
6 Month
+71.7%
+71.7%
1 Year
+133.5%
+133.5%

More News

Read More
News headline image
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
From Moderna, Inc.
Via ACCESS Newswire
News headline image
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead ↗
Via The Motley Fool
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Moderna to Host Investor Event - Science Day
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Why Is Moderna (MRNA) Stock Soaring Today
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
From Moderna, Inc.
Via ACCESS Newswire
News headline image
A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence
News headline image
3 Stocks Under $50 That Fall Short
Via StockStory
News headline image
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? ↗
Via The Motley Fool
Topics Initial Public Offering
News headline image
3 Unpopular Stocks We Steer Clear Of
Via StockStory
News headline image
Does Moderna Need to Start Making Money? ↗
Via The Motley Fool
News headline image
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
Via ACCESS Newswire
News headline image
3 ETFs For the Coming Genomics Revolution ↗
Via MarketBeat
Topics ETFs
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
Via Investor Brand Network
NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
From BioMedWire
Via GlobeNewswire
News headline image
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 ↗
Via The Motley Fool
News headline image
Moderna to Present at Upcoming Conference in June 2026
Via ACCESS Newswire

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 59.94
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 06/22/26 09:40 AM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 23.61B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 24B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.